ACRS - Aclaris Therapeutics, Inc.

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q1 FY2014 Dec 31, 2013 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q4 FY2012 Dec 31, 2012 10-K ↗
Revenue Growth YoY (%)	37.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+365%)	-85.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1174%)	-24.1% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-401%)	-35.8% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-547%)	-39.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-592%)	-47.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-695%)	-53.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-765%)	48.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+500%)	-5.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-164%)	126.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1483%)	-51.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-740%)	22.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+179%)	74.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+825%)	416.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5107%)	1046.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+12979%)	-16.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-303%)	-18.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-328%)	-5.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-162%)	14.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+81%)	-10.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-236%)	26.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+229%)	44.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+454%)	47.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+493%)	-65.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-914%)	-72.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1001%)	-38.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-578%)	-39.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-595%)	59.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+644%)	350.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4286%)	77.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+867%)	138.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1625%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-25.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	86.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-9.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	13.3% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-5950.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	73.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	64.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	42.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	95.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-36.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-35.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-35.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-10.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	14.3% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-31.4% Weak ↓ Weak Declining Year-over-year change in net income	79.5% Excellent ↑ Excellent Improving Year-over-year change in net income	11.0% Fair ↑ Fair Improving Year-over-year change in net income	11.0% Fair ↑ Fair Improving Year-over-year change in net income	11.0% Fair ↑ Fair Improving Year-over-year change in net income	-6375.7% Weak ↓ Weak Declining Year-over-year change in net income	39.8% Excellent ↓ Excellent Declining Year-over-year change in net income	39.8% Excellent ↑ Excellent Improving Year-over-year change in net income	39.8% Excellent ↑ Excellent Improving Year-over-year change in net income	94.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-49.9% Weak ↓ Weak Declining Year-over-year change in net income	-49.9% Weak ↓ Weak Declining Year-over-year change in net income	-49.9% Weak ↓ Weak Declining Year-over-year change in net income	-21.2% Weak ↓ Weak Declining Year-over-year change in net income	34.7% Excellent ↑ Excellent Improving Year-over-year change in net income	34.7% Excellent ↑ Excellent Improving Year-over-year change in net income	34.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-73.1% Weak ↑ Weak Improving Year-over-year change in net income	-84.5% Weak ↓ Weak Declining Year-over-year change in net income	-84.5% Weak ↓ Weak Declining Year-over-year change in net income	-84.5% Weak ↓ Weak Declining Year-over-year change in net income	29.2% Excellent ↓ Excellent Declining Year-over-year change in net income	58.5% Excellent → Excellent Stable Year-over-year change in net income	58.5% Excellent ↑ Excellent Improving Year-over-year change in net income	58.5% Excellent ↑ Excellent Improving Year-over-year change in net income	51.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-14.7% Weak ↑ Weak Improving Year-over-year change in net income	-20.3% Weak ↑ Weak Improving Year-over-year change in net income	-24.3% Weak ↑ Weak Improving Year-over-year change in net income	-68.1% Weak ↑ Weak Improving Year-over-year change in net income	-80.0% Weak ↑ Weak Improving Year-over-year change in net income	-110.4% Weak ↓ Weak Declining Year-over-year change in net income	-140.7% Weak ↓ Weak Declining Year-over-year change in net income	-99.9% Weak ↓ Weak Declining Year-over-year change in net income	-70.1% Weak ↓ Weak Declining Year-over-year change in net income	-15.3% Weak ↑ Weak Improving Year-over-year change in net income	3.7% Caution ↑ Caution Improving Year-over-year change in net income	-143.4% Weak ↑ Weak Improving Year-over-year change in net income	-0.6% Weak ↑ Weak Improving Year-over-year change in net income	-396.2% Weak ↓ Weak Declining Year-over-year change in net income	-397.1% Weak ↓ Weak Declining Year-over-year change in net income	-81.5% Weak Weak Year-over-year change in net income	-300.2% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	-31.7% Weak Weak Year-over-year change in free cash flow	—	N/M	52.8% Excellent Excellent Year-over-year change in free cash flow	63.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	26.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-17.0% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-7.6% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-44.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-44.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	5.2% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	0.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	83.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	37.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	14.9% Good ↓ Good Declining Compound annual revenue growth over 3 years	10.5% Good ↓ Good Declining Compound annual revenue growth over 3 years	123.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	85.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-3.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	21.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	92.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	168.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-36.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-33.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-5.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	0.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-20.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	16.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	16.5% Excellent Excellent Compound annual revenue growth over 3 years	28.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	2.4% Caution ↓ Caution Declining Compound annual revenue growth over 5 years	-3.9% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	17.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-2.8% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	0.7% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	53.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	34.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-14.0% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-13.8% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	58.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	41.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-12.7% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	17.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	50.7% Excellent Excellent Compound annual revenue growth over 5 years	94.5% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q1 FY2014 Dec 31, 2013 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q4 FY2012 Dec 31, 2012 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	-240.9% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1706%)	-464.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3198%)	—	-23.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-254%)	-340.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2368%)	—	—	-375.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2600%)	-109.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-832%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	-457.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3910%)	—	—	—	-389.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3348%)	—	—	-8.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-171%)	-303.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2628%)	—	—	-356.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3070%)	-98.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-923%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	-332.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-97.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-446.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-41.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-247.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	-492.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.09x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-1.30x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.24x Good Good Free cash flow relative to reported net income Optimal: > 1x	4.83x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.70x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.12x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.43x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.44x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.73x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.71x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q1 FY2014 Dec 31, 2013 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q4 FY2012 Dec 31, 2012 10-K ↗
Return on Invested Capital (%)	-12.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-50.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-2.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-23.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-7.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	22.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	9.9% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-11.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-14.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-45.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-10.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-7.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-8.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-6.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-14.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-13.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-14.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-19.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-7.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-12.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-25.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-13.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-192%)	-19.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-228%)	-12.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-184%)	-11.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-10.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-62.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-514%)	-13.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	-12.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-184%)	-11.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-180%)	-0.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-106%)	-18.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-220%)	-15.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-204%)	-15.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-206%)	-14.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-193%)	-8.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-157%)	-8.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	-10.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-11.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-177%)	-13.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-189%)	-12.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	-25.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-271%)	-35.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-333%)	-38.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-355%)	-31.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-310%)	-26.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-279%)	-26.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-277%)	-44.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-394%)	-27.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-282%)	-20.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-237%)	-17.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-219%)	-22.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-249%)	-17.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-219%)	-15.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-201%)	-10.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-168%)	-7.4% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	-8.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	-7.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-152%)	-6.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	-13.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-188%)	-14.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-15.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-204%)	-5.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	27.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+86%)	—	—	12.5% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-17%)	—	—	—	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q1 FY2014 Dec 31, 2013 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q4 FY2012 Dec 31, 2012 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.05x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.10x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-84%)	—	0.26x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-57%)	0.21x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-64%)	0.18x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-70%)	—	0.35x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-42%)	0.22x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-64%)	0.16x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-73%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-28.66M	$-19.96M	$-25.26M	$-25.40M	$-30.36M	$-24.57M	—	—	$-35.84M	$-39.88M	$-39.04M	$-31.15M	$-44.72M	$-45.28M	$-61.65M	$-68.26M	$-36.34M	—	—	$-102.72M	$-24.57M	—	$-13.03M	$10.57M	$10.57M	—	$29.93M	$29.92M	$29.92M	—	—	—	$-54.88M	—	$-60.05M	$-32.71M	$-23.68M	—	$-17.80M	$-31.82M	$-13.13M	$-9.85M	$-25.42M	$-9.85M	$-8.47M	$-10.76M	$-18.89M	$-9.59M	$-9.59M	$-19.04M
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.60x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.38x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-1.04x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.95x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.71x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-1.33x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.61x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.85x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q1 FY2014 Dec 31, 2013 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q4 FY2012 Dec 31, 2012 10-K ↗
Revenue per Share (USD)	$0.02	—	$0.03	$0.01	$0.01	—	$0.06	$0.04	$0.03	—	$0.13	$0.03	$0.04	—	$0.29	$0.02	$0.02	—	$0.03	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.15	$-0.16	$-0.12	$-0.13	$-0.12	$-1.21	$-0.11	$-0.15	$-0.24	$-0.02	$-0.41	$-0.42	$-0.42	$-0.41	$-0.30	$-0.31	$-0.31	$-0.37	$-0.35	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.14	—	$-0.09	$-0.08	$-0.11	—	$0.31	$-0.17	$-0.29	—	—	—	$-0.40	—	—	—	$-0.34	—	$-0.17	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.03	$0.86	$1.11	$1.22	$1.33	$1.44	$1.82	$1.88	$1.99	$2.22	$2.21	$2.54	$2.63	$2.96	$3.30	$3.54	$2.92	—	$3.54	$3.82	$2.16	—	$0.95	$1.16	$1.39	—	$2.06	$3.32	$4.42	—	$4.72	$5.63	$6.49	—	$7.92	$6.29	$6.14	—	$3.79	$4.22	$4.10	—	$-13.96	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$1.03	$0.86	$1.11	$1.22	$1.33	$1.44	$1.82	$1.88	$1.99	$2.22	$2.11	$2.44	$2.53	$2.86	$3.19	$3.43	$2.80	—	$3.54	$3.70	$2.02	—	$0.78	$0.99	$1.22	—	$1.89	$1.63	$2.24	—	$3.89	$4.79	$5.65	—	$7.08	$6.29	$6.14	—	$3.79	$4.22	$4.10	—	$-13.96	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	128.81M	—	122.62M	122.58M	122.39M	—	71.38M	71.29M	71.07M	—	70.81M	70.63M	66.87M	—	66.68M	65.99M	61.43M	—	61.22M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q1 FY2014 Dec 31, 2013 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q4 FY2012 Dec 31, 2012 10-K ↗
Working Capital (USD)	$82.86M	$67.67M	$74.96M	$77.36M	$87.28M	$94.36M	—	—	$115.26M	$97.90M	$95.75M	$110.11M	$166.10M	$209.61M	$236.78M	$243.14M	$174.16M	—	—	$226.34M	$120.00M	—	$45.21M	$53.21M	$62.11M	—	$106.38M	$95.15M	$120.58M	—	$123.24M	$151.10M	$178.43M	—	$224.13M	$167.38M	$151.71M	—	$81.00M	$90.13M	$83.10M	—	$37.46M	—	—	—	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$10.73M	$10.69M	—	$10.61M	$10.57M	$10.57M	—	$29.93M	$29.92M	$29.92M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$143.65M	$103.08M	$120.10M	$131.74M	$144.07M	$155.55M	$130.15M	$133.82M	$142.01M	$157.18M	$156.33M	$179.75M	$176.81M	$197.62M	$219.84M	$235.75M	$180.20M	$197.34M	$216.58M	$233.81M	$112.29M	$37.65M	$40.76M	$49.37M	$58.17M	$69.91M	$85.28M	$137.23M	$182.25M	$215.12M	$146.33M	$174.20M	$200.47M	$225.26M	$244.26M	$168.14M	$160.29M	$169.49M	$81.12M	$90.24M	$83.21M	$92.52M	$-38.12M	—	—	$-20.75M	—	—	$-9.16M	$-2.19M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-K ↗	Q3 FY2015 Sep 30, 2015 10-Q ↗	Q2 FY2015 Jun 30, 2015 10-Q ↗	Q1 FY2015 Mar 31, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-K ↗	Q3 FY2014 Sep 30, 2014 10-Q ↗	Q1 FY2014 Dec 31, 2013 10-Q ↗	Q4 FY2013 Dec 31, 2013 10-K ↗	Q4 FY2012 Dec 31, 2012 10-K ↗
Sales/Revenue/Turnover (USD)	$2.00M	$1.29M	$3.30M	$1.78M	$1.46M	$9.21M	$4.35M	$2.77M	$2.40M	$17.57M	$9.28M	$1.87M	$2.53M	$7.75M	$19.02M	$1.53M	$1.45M	$1.50M	$1.66M	$1.82M	$1.78M	$1.58M	$1.45M	$2.05M	$1.41M	$1.09M	$983.00K	$5.87M	$5.04M	$1.77M	$1.63M	$3.68M	$1.12M	$999.00K	$684.00K	—	—	—	—	—	—	—	$0.00	—	—	—	$0.00	—	—	—
Depreciation Expense (USD)	$102.00K	$102.00K	$110.00K	$114.00K	$128.00K	$143.00K	$179.00K	$242.00K	$243.00K	$228.00K	$200.00K	$200.00K	$198.00K	$190.00K	$200.00K	$200.00K	$208.00K	$197.00K	$191.00K	$200.00K	$288.00K	$-449.00K	$300.00K	$297.00K	$576.00K	$320.00K	$324.00K	$394.00K	$2.23M	$958.00K	$366.00K	$296.00K	$222.00K	$181.00K	$103.00K	$55.00K	$50.00K	$40.00K	$32.00K	$27.00K	$21.00K	$33.00K	$32.00K	$22.00K	$3.00K	$3.00K	$3.00K	—	—	—
Net Income, GAAP (USD)	$-19.82M	$-19.80M	$-15.09M	$-15.09M	$-15.09M	$-96.55M	$-16.94M	$-16.94M	$-16.94M	$-1.49M	$-28.16M	$-28.16M	$-28.16M	$-27.64M	$-18.79M	$-18.79M	$-18.79M	$-22.80M	$-28.75M	$-28.75M	$-28.75M	$-13.17M	$-15.59M	$-15.59M	$-15.59M	$-18.59M	$-37.56M	$-37.56M	$-37.56M	$-38.55M	$-32.74M	$-31.22M	$-30.23M	$-22.93M	$-18.19M	$-14.84M	$-12.56M	$-11.47M	$-10.69M	$-12.87M	$-13.04M	$-4.71M	$-10.63M	$-2.59M	$-2.62M	$-2.60M	$-2.66M	—	—	—
Operating Cash Flow (USD)	$-18.15M	$-13.13M	$-10.93M	$-9.99M	$-13.06M	$-8.94M	$22.00M	$-12.32M	$-20.82M	$-6.76M	—	—	$-26.35M	$-19.11M	—	—	$-20.97M	$-17.07M	$-10.61M	—	$-12.23M	$-8.86M	—	—	$-6.80M	$-20.39M	—	—	$-31.32M	$-27.25M	—	—	$-21.87M	$-18.21M	—	—	—	$-8.07M	—	—	—	—	—	—	—	—	—	—	—	—

Aclaris Therapeutics, Inc.

Analytical Summary

50-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ACRS with peers